PubRank

C R Manclark

Author PubWeight™ 112.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981 7.58
2 Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A 1976 3.57
3 Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. J Biol Chem 1983 3.31
4 Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun 1983 2.85
5 Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun 1981 2.77
6 Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect Immun 1988 2.55
7 ADP-ribosylation of transducin by pertussis toxin blocks the light-stimulated hydrolysis of GTP and cGMP in retinal photoreceptors. J Biol Chem 1984 2.39
8 Aerosol infection of mice with Bordetella pertussis. Infect Immun 1980 2.31
9 Phase-shift markers in Bordetella: alterations in envelope proteins. J Infect Dis 1981 2.23
10 Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun 1986 2.18
11 Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice. J Infect Dis 1984 1.96
12 Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health 1988 1.93
13 Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies. Infect Immun 1988 1.92
14 Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein. J Biol Chem 1988 1.88
15 Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun 1979 1.83
16 Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun 1983 1.77
17 Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun 1988 1.71
18 Immunologic response to early and routine DTP immunization in infants. Pediatrics 1984 1.71
19 Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun 1989 1.71
20 Pertussis toxin substrate, the putative Ni component of adenylyl cyclases, is an alpha beta heterodimer regulated by guanine nucleotide and magnesium. Proc Natl Acad Sci U S A 1983 1.67
21 Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J Exp Med 1990 1.67
22 Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics 1988 1.66
23 Ns and Ni, the stimulatory and inhibitory regulatory components of adenylyl cyclases. Purification of the human erythrocyte proteins without the use of activating regulatory ligands. J Biol Chem 1984 1.62
24 Stimulation and inhibition of adenylyl cyclases mediated by distinct regulatory proteins. Nature 1983 1.59
25 Nonfermentative bacilli associated with man. I. Nomenclature. Am J Clin Pathol 1970 1.57
26 Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun 1987 1.52
27 Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol 1994 1.49
28 Purification and characterization of fimbriae isolated from Bordetella pertussis. Infect Immun 1985 1.47
29 Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function. Hybridoma 1989 1.43
30 A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J Infect Dis 1988 1.37
31 Structural characterization of pertussis toxin A subunit. J Biol Chem 1987 1.36
32 Immune response to the B oligomer of pertussis toxin. Infect Immun 1987 1.36
33 Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies. Infect Immun 1989 1.32
34 Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies. Pediatr Infect Dis 1984 1.25
35 Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line. Proc Natl Acad Sci U S A 1985 1.24
36 Adenine nucleotides promote dissociation of pertussis toxin subunits. J Biol Chem 1986 1.17
37 Cloning and sequencing of the structural gene for the porin protein of Bordetella pertussis. Mol Microbiol 1991 1.13
38 In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor. Infect Immun 1984 1.12
39 Biphasic effect of pertussis vaccine on serum insulin in mice. Infect Immun 1983 1.11
40 Stimulation of the thiol-dependent ADP-ribosyltransferase and NAD glycohydrolase activities of Bordetella pertussis toxin by adenine nucleotides, phospholipids, and detergents. Biochemistry 1986 1.10
41 Phase-shift markers in the genus Bordetella: loss of cytochrome d-629 in phase IV variants. Microbios 1981 1.10
42 Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae. Infect Immun 1987 1.10
43 Mechanism of pertussis toxin B oligomer-mediated protection against Bordetella pertussis respiratory infection. Infect Immun 1990 1.08
44 Lymphocytosis-promoting factor of Bordetella pertussis alters mononuclear phagocyte circulation and response to inflammation. Infect Immun 1984 1.07
45 Regulation of Bordetella pertussis extracytoplasmic adenylate cyclase. Adv Cyclic Nucleotide Res 1978 1.06
46 Pertussis in a previously immunized child with human immunodeficiency virus infection. J Pediatr 1989 1.05
47 Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J Infect Dis 1991 1.04
48 Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen. Dev Biol Stand 1985 1.02
49 Pertussis vaccine research. Bull World Health Organ 1981 0.99
50 Mechanisms in the vectorial receptor-adenylate cyclase signal transduction. Adv Cyclic Nucleotide Protein Phosphorylation Res 1984 0.98
51 A protein activator for the adenylate cyclase of Bordetella pertussis. J Biol Chem 1979 0.98
52 Adenyl cyclase in Bordetella pertussis vaccines. J Infect Dis 1977 0.97
53 Proliferative response of immune mouse T-lymphocytes to the lymphocytosis-promoting factor of Bordetella pertussis. Infect Immun 1984 0.95
54 Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatr Infect Dis J 1989 0.94
55 Evaluation of a ribosomal vaccine against pertussis. Infect Immun 1979 0.93
56 Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J Infect Dis 1988 0.92
57 Selective breeding to establish a standard mouse for pertussis vaccine bioassay. II. Bioresponses of mice susceptible and resistant to sensitization by pertussis vaccine HSF. J Biol Stand 1975 0.92
58 Immune response to dimeric subunits of the pertussis toxin B oligomer. Infect Immun 1989 0.89
59 The current status of pertussis vaccine: an overview. Adv Appl Microbiol 1976 0.88
60 The pattern of the immune response in vibriosis. J Pathol Bacteriol 1965 0.88
61 Role of cysteine 41 of the A subunit of pertussis toxin. J Biol Chem 1989 0.87
62 Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice. Infect Immun 1985 0.87
63 Characterization of the filamentous hemagglutinin from Bordetella pertussis by gel electrophoresis. Mol Cell Biochem 1986 0.87
64 Spurious protein activators of Bordetella pertussis adenylate cyclase. Eur J Biochem 1981 0.86
65 Assay of pertussis vaccine toxicity by a rat-paw-oedema method. J Med Microbiol 1977 0.83
66 Binding of ATP by pertussis toxin and isolated toxin subunits. Biochemistry 1990 0.82
67 Effects of exogenous agents on the action of Bordetella parapertussis heat-labile toxin on guinea pig skin. Infect Immun 1990 0.82
68 Involvement of filamentous hemagglutinin in the adherence of Bordetella pertussis to human WiDr cell cultures. Dev Biol Stand 1985 0.82
69 Structural and functional properties of a 69-kilodalton outer membrane protein of Bordetella pertussis. Tokai J Exp Clin Med 1988 0.81
70 Prospects for a new acellular pertussis vaccine. Ann Inst Pasteur Microbiol 1986 0.81
71 Determination of T cell epitopes on the S1 subunit of pertussis toxin. J Immunol 1990 0.79
72 Biochemical properties of pertussis toxin. Tokai J Exp Clin Med 1988 0.78
73 Bordetella pertussis does not induce beta-adrenergic blockade. Infect Immun 1978 0.78
74 Purification and analysis of the antigenicity of a 69,000 Da protein from Bordetella pertussis. FEMS Microbiol Lett 1990 0.77
75 DTP vaccine reactions: effect of prior reactions on rate of subsequent reactions. Dev Biol Stand 1985 0.77
76 Outbreaks of pertussis in the United States: the Wisconsin experience. Tokai J Exp Clin Med 1988 0.76
77 Altered mononuclear phagocyte function in mice treated with the lymphocytosis promoting factor of Bordetella pertussis. Dev Biol Stand 1985 0.76
78 [Research on whooping cough vaccine]. Bull World Health Organ 1981 0.75
79 Inhibition of heat-labile toxin from Bordetella parapertussis by fatty acids. Infect Immun 1990 0.75
80 Simultaneous administration of live attenuated measles vaccine with DTP vaccine. Pediatrics 1978 0.75
81 From the National Institutes of Health: summary of an International Symposium on Pertussis. J Infect Dis 1979 0.75
82 Repression of adenylate cyclase in the genus Bordetella. Microbios 1982 0.75
83 Development of a cell culture assay for Bordetella parapertussis heat-labile toxin. Biologicals 1990 0.75
84 Recent advances in the development of pertussis vaccines. Biotechnology 1992 0.75